Eighteen out of these 24 participants had diagnostic variants in PMM2 (HGNC:9115) and their phenotypes aligned with congenital disorder of glycosylation had type Ia, rather than polycystic kidney disease with hyperinsulinemic hypoglycemia that is included in the Generation Study. Here, PMM2 is linked to congenital disorder of glycosylation.